p31.sup.comet-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2
Mad2, a key component of the spindle checkpoint, is closely associated with chromosomal instability and poor prognosis in cancer. p31.sup.comet is a Mad2-interacting protein that serves as a spindle checkpoint silencer at mitosis. In this study, we showed that p31.sup.comet -induced apoptosis and se...
Gespeichert in:
Veröffentlicht in: | PloS one 2015-11, Vol.10 (11) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Mad2, a key component of the spindle checkpoint, is closely associated with chromosomal instability and poor prognosis in cancer. p31.sup.comet is a Mad2-interacting protein that serves as a spindle checkpoint silencer at mitosis. In this study, we showed that p31.sup.comet -induced apoptosis and senescence occur via counteraction of Mad2 activity. Upon retroviral transduction of p31.sup.comet, the majority of human cancer cell lines tested lost the ability to form colonies in a low-density seeding assay. Cancer cells with p31.sup.comet overexpression underwent distinct apoptosis and/or senescence, irrespective of p53 status, confirming the cytotoxicity of p31.sup.comet . Interestingly, both cytotoxic and Mad2 binding activities were eliminated upon deletion of the C-terminal 30 amino acids of p31.sup.comet . Point mutation or deletion of the region affecting Mad2 binding additionally abolished cytotoxic activity. Consistently, wild-type Mad2 interacting with p31.sup.comet, but not its non-binding mutant, inhibited cell death, indicating that the mechanism of p31.sup.comet -induced cell death involves Mad2 inactivation. Our results clearly suggest that the regions of p31.sup.comet affecting interactions with Mad2, including the C-terminus, are essential for induction of cell death. The finding that p31.sup.comet -induced cell death is mediated by interactions with Mad2 that lead to its inactivation is potentially applicable in anticancer therapy. |
---|---|
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0141523 |